PC3303 - Integrated Therapeutics 3
|Student Contribution Band:
||College of Medicine & Dentistry
Mental health is becoming an increasingly important aspect of daily living, with conditions
such as depression, anxiety, schizophrenia, and bipolar disorder affecting a significant
proportion of the Australian population. Both neurological and psychiatric conditions
require regular communication with health professionals, including pharmacists, to
ensure that the treatment plan being enacted is managing the condition(s) effectively.
Chronic pain can have a dramatic effect on mental health, with substance abuse disorders
such as nicotine, alcohol, and opioid addictions often coinciding with pain and mental
health disorders. Similarly chronic respiratory conditions such as asthma and chronic
obstructive pulmonary disease (COPD) represent a significant health burden on the
wider community and can have large implications on quality of life. Students in this
subject will learn about the pathophysiology of multiple conditions within these fields,
and will have a strong understanding of the vast array of medications available for
the conditions presented. They will also improve their professional communication
skills with both patients and prescribers to ensure the best outcomes from treatment.
- Describe the pathophysiology and clinical presentation of common neurological, psychiatric,
musculoskeletal and respiratory conditions relevant to pharmacy practice;
- Demonstrate appropriate screening and clinical skills necessary for the prevention,
identification, and management of these conditions;
- Recommend suitable drug treatments, including prescription, over-the-counter, complementary
and non-pharmacological treatment options;
- Develop skills relating to the use of clinical guidelines and their application to
the management of patients;
- Demonstrate professional communication for patients and other health professionals
regarding these conditions.
- Invigilated > End of semester exam - (30%)
- Invigilated > Other exams - (20%)
- Quizzes and tests - (25%)
- Assignments - (25%).
|As this is a core level 3 subject in the BPharm(Hons)/MPharm pathway, students will
be expected to have completed all core level 1 and 2 subjects.
Study Period 2
|Census Date 27-Aug-2020
||Dr John Smithson
||Professor Beverley Glass, Dr Martina Mylrea.
The student workload for this
credit point subject is approximately
- 50 hours lectures
- 30 hours tutorials
- 36 hours workshops/Seminars
- assessment and self-directed study
Minor variations might occur due to the continuous Subject quality improvement process,
and in case
of minor variation(s) in assessment details, the Subject Outline represents the latest